Direvo Overview
- Year Founded
-
2008
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Liquidation
Direvo General Information
Description
Provider of biotechnology products intended to be used for industrial usage, chemical processing, and medical applications. The company's products are biology-based and process sustainable resources for use in non-pharmaceutical industries with a focus on biomass conversion, enabling clients to avail sustainable and profitable processes required by the developing bio-economy.
Contact Information
Website
www.direvo.comCorporate Office
- Nattermannallee 1
- 50829 Cologne
- Germany
Corporate Office
- Nattermannallee 1
- 50829 Cologne
- Germany
Direvo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Bankruptcy: Liquidation | 07-Oct-2021 | Completed | Bankruptcy: Liquidation | |||
| 6. Secondary Transaction - Private | 01-Jun-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 18-Mar-2013 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 14-Apr-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Feb-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 16-Sep-2008 | $11.6M | $11.6M | Completed | Generating Revenue | |
| 1. Spin-Off | 01-Jan-2008 | Completed | Generating Revenue |
Direvo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Direvo Patents
Direvo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3541948-A1 | Method to improve the nutritional quality of fermentation by-products | Active | 17-Nov-2016 | ||
| EP-3541948-B1 | Method to improve the nutritional quality of fermentation by-products | Active | 17-Nov-2016 | ||
| ES-2709476-T3 | Dehydration methods in fermentation processes | Active | 05-Aug-2014 | ||
| ES-2699845-T3 | Improved fermentation processes using xylanase and pectinase | Active | 05-Aug-2014 | ||
| ES-2699677-T3 | Improved batch time in fermentation processes using xylanase and pectinase | Active | 05-Aug-2014 | C12P7/06 |
Direvo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Direvo Acquisitions (1)
Direvo’s most recent deal was a Merger/Acquisition with AC Biotec. The deal was made on 06-Nov-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AC Biotec | 06-Nov-2007 | Merger/Acquisition | Biotechnology |
Direvo FAQs
-
When was Direvo founded?
Direvo was founded in 2008.
-
Where is Direvo headquartered?
Direvo is headquartered in Cologne, Germany.
-
What is the size of Direvo?
Direvo has 5 total employees.
-
What industry is Direvo in?
Direvo’s primary industry is Discovery Tools (Healthcare).
-
Is Direvo a private or public company?
Direvo is a Private company.
-
What is Direvo’s current revenue?
The current revenue for Direvo is .
-
How much funding has Direvo raised over time?
Direvo has raised $32.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
